Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Knobloch, D. Jungck, K. Urban, A. Koch (Bochum, Germany). Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD. Eur Respir J 2011; 38: Suppl. 55, 4102

Member's Comments

No comment yet.

Related content which might interest you: Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006 Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM) Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005 Inhibition of cytokine release from alveolar macrophages in sarcoidosis by pentoxifylline: comparison with dexamethasone Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001 Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 Cigarette smoke can increase the neutrophil recruitment in the airways of COPD patients by increasing PGE2 release in alveolar macrophages (AM) Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages in vitro Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Neutrophil extracellular traps promoted alveolar macrophages pyroptosis in LPS induced ALI/ARDS Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Source: Eur Respir J 2002; 20: 1198-1205 Year: 2002 The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Fluticasone increases in vitro efferocytosis by human alveolar macrophages Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008